Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,310 | 160,614 | 52,540 | 13,969 | 38,889 |
| Marketable Securities | 645,838 | 611,265 | 193,112 | 293,112 | 322,985 |
| TOTAL | $723,590 | $782,654 | $256,381 | $316,493 | $367,307 |
| Non-Current Assets | |||||
| PPE Net | 39,112 | 18,726 | 13,607 | 8,536 | 5,856 |
| Other Non-Current Assets | 19,592 | 16,187 | 18,310 | 19,626 | 22,583 |
| TOTAL | $58,704 | $34,913 | $31,917 | $28,162 | $28,439 |
| Total Assets | $782,294 | $817,567 | $288,298 | $344,655 | $395,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,794 | 10,238 | 10,614 | 15,567 | 9,921 |
| Accrued Expenses | 32,400 | 38,794 | 22,500 | 16,265 | 16,322 |
| TOTAL | $64,390 | $54,905 | $39,545 | $39,084 | $34,613 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,063 | 4,353 | 5,440 | 6,600 | 6,070 |
| TOTAL | $6,063 | $4,353 | $5,440 | $6,600 | $6,070 |
| Total Liabilities | $70,453 | $59,258 | $44,985 | $45,684 | $40,683 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,687 | 146,443 | 126,862 | 126,499 | 126,195 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -761,796 | -703,225 | -640,207 | -570,612 | -507,044 |
| Other shareholders' equity | 155 | 317 | 912 | 220 | 239 |
| TOTAL | $711,841 | $758,309 | $243,313 | $298,971 | $355,063 |
| Total Liabilities And Equity | $782,294 | $817,567 | $288,298 | $344,655 | $395,746 |